192 related articles for article (PubMed ID: 21666093)
1. Treatment of ciprofloxacin nonsusceptible urinary tract infections with ciprofloxacin.
Jeffres MN; Shuster JE; Barclay SM
Ann Pharmacother; 2011 Jun; 45(6):824-5. PubMed ID: 21666093
[No Abstract] [Full Text] [Related]
2. [Microbiological evaluation of ciprofloxacin efficacy for treatment of urinary tract infections].
Kalisz J; Denys A; Szczerba W; Rusinek A; Rogowska-Kalisz A
Med Dosw Mikrobiol; 1996; 48(3-4):169-75. PubMed ID: 9182138
[TBL] [Abstract][Full Text] [Related]
3. Uncomplicate the treatment of uncomplicated urinary tract infections.
Ditmanson LF; Apgar DA
Arch Intern Med; 1996 Jan; 156(1):111-3. PubMed ID: 8526690
[No Abstract] [Full Text] [Related]
4. Study shows common UTI bacteria are most susceptible and least resistant to ciprofloxacin.
Urol Nurs; 2001 Aug; 21(4):303-5. PubMed ID: 11998460
[No Abstract] [Full Text] [Related]
5. [Therapy of urinary tract infections with ciprofloxacin].
Horcicková M; Prát V; Matousovic K; Hatala M; Liska M; Milotová Z
Cas Lek Cesk; 1987 Sep; 126(39):1221-4. PubMed ID: 3664597
[No Abstract] [Full Text] [Related]
6. Ciprofloxacin in the treatment of complicated urinary tract infections.
Naber K; Sörgel F
Chemioterapia; 1987 Jun; 6(2 Suppl):522-3. PubMed ID: 3509488
[No Abstract] [Full Text] [Related]
7. Ciprofloxacin monotherapy and bacterial keratitis.
Katz HR
Ophthalmology; 1999 Oct; 106(10):1853-4. PubMed ID: 10519570
[No Abstract] [Full Text] [Related]
8. A high incidence of ciprofloxacin resistance in urinary isolates in eastern Nepal.
Srinivasa H; Parija SC; Bhattacharya S; Sehgal R
J Commun Dis; 1999 Mar; 31(1):45-7. PubMed ID: 10810586
[TBL] [Abstract][Full Text] [Related]
9. [The in vitro activity of ofloxacin, pefloxacin and ciprofloxacin against various gram negative bacteria isolated from urinary tract infections].
Tunçkanat F; Yuluğ N
Mikrobiyol Bul; 1988; 22(3):187-92. PubMed ID: 3252111
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
[TBL] [Abstract][Full Text] [Related]
11. In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
Obana Y; Nishino T
Drugs Exp Clin Res; 1989; 15(2):53-8. PubMed ID: 2661182
[TBL] [Abstract][Full Text] [Related]
12. [Susceptibility to norfloxacin of some bacterial strains causing urinary infections].
Tuchiluş C; Poiată A; Bădicuţ I; Buiuc D
Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):383-6. PubMed ID: 16607805
[TBL] [Abstract][Full Text] [Related]
13. [Maxaquin and ciprofloxacin in the treatment of complicated and recurrent urinary infections in adults].
Savitskaia KI; Trapeznikova MF; Nekhorosheva AG; Solodilova OE; Nasonov VN; Dutov VV; Kalinin VN; Shanina AG; Rusanova EV
Klin Med (Mosk); 1994; 72(2):38-42. PubMed ID: 8015241
[TBL] [Abstract][Full Text] [Related]
14. [Quinolone resistance of Escherichia coli strains isolated from urinary tract infections].
Agulla A; Montes I
Enferm Infecc Microbiol Clin; 1994; 12(6):322. PubMed ID: 8080877
[No Abstract] [Full Text] [Related]
15. Ten-year survey of quinolone resistance in Escherichia coli causing urinary tract infections.
Pérez-Trallero E; Urbieta M; Jimenez D; García-Arenzana JM; Cilla G
Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):349-51. PubMed ID: 8354301
[TBL] [Abstract][Full Text] [Related]
16. Emergence of ciprofloxacin resistance in Escherichia coli isolates from outpatient urine samples.
Gagliotti C; Nobilio L; Moro ML;
Clin Microbiol Infect; 2007 Mar; 13(3):328-31. PubMed ID: 17391392
[TBL] [Abstract][Full Text] [Related]
17. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
Iravani A; Klimberg I; Briefer C; Munera C; Kowalsky SF; Echols RM
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():67-75. PubMed ID: 10225575
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of ofloxacin, ciprofloxacin and NY-198 in experimentally infected normal and alloxan-induced diabetic mice.
Obana Y; Nishino T
Drugs Exp Clin Res; 1988; 14(5):327-31. PubMed ID: 3219995
[TBL] [Abstract][Full Text] [Related]
19. Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women.
Auquer F; Cordón F; Gorina E; Caballero JC; Adalid C; Batlle J;
Clin Microbiol Infect; 2002 Jan; 8(1):50-4. PubMed ID: 11906502
[TBL] [Abstract][Full Text] [Related]
20. Temafloxacin vs ciprofloxacin for UTI.
Ganiats TG; Norcross WA
J Fam Pract; 1992 Jul; 35(1):14, 16, 18. PubMed ID: 1319461
[No Abstract] [Full Text] [Related]
[Next] [New Search]
